NASDAQ · Financial Statements
Applied Genetic Technologies Corporation (AGTC) Financial Statements
$0.39
NASDAQ: AGTC
Overview Financials Dividend Applied Genetic Technologies Corporation most recently reported annual revenue of $0, net profit of $-71.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022 Revenue $24.0M $42.0M $2.0M $1.0M $0 Operating Profit $-22.0M $-4.0M $-47.0M $-58.0M $-66.0M Net Profit $-21.0M $-2.0M $-46.0M $-58.0M $-71.0M EPS $-1.18 $-0.11 $-2.17 $-1.77 $-1.59 Op Margin -92.5% -10.4% -1913.7% -11690.2% -20390.5%
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022 Total Assets $119.0M $92.0M $100.0M $127.0M $67.0M Total Liabilities $19.0M $14.0M $29.0M $41.0M $37.0M Cash $31.0M $27.0M $38.0M $105.0M $46.0M Borrowings $0 $0 $11.0M $24.0M $22.0M
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022 Operating Cash Flow $-33.0M $-23.0M $-42.0M $-51.0M $-66.0M Investing Cash Flow $32.0M $19.0M $7.0M $36.0M $-2.0M Financing Cash Flow $0 $0 $45.0M $80.0M $7.0M Net Cash Flow $0 $-4.0M $12.0M $67.0M $-59.0M Free Cash Flow $-33.0M $-24.0M $-43.0M $-53.0M $-68.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA 0.37 FCF Yield — Quick Ratio 1.97 Interest Coverage -24.78 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock